Press release
Leading Companies Enhancing Their Presence in the Veterinary Clinical Trials Market
Veterinary Clinical Trials Market
Projected Market Size and Growth of the Veterinary Clinical Trials Market
The veterinary clinical trials industry is anticipated to experience substantial growth, reaching a market value of $7.61 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 9.4%. Several factors are driving this upward trajectory, including increased investments in veterinary drug development, the broader adoption of precision medicine tailored for animals, and a growing involvement of Contract Research Organizations (CROs) in veterinary trials. Additionally, there is a heightened focus on chronic conditions and oncology indications, along with a rising use of real-world evidence in animal health research. Key trends shaping the market during this period involve the growing implementation of digital trial management platforms, the rise of genomic and biomarker-based studies, increasing emphasis on companion animal clinical research, expansion of multicenter veterinary trials, and stricter attention to data integrity and regulatory compliance.
Download a free report of the veterinary clinical trials market report:
https://www.thebusinessresearchcompany.com/report/veterinary-clinical-trials-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Influencing the Veterinary Clinical Trials Industry
Several prominent organizations dominate the veterinary clinical trials landscape. The major players include Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Charles River Laboratories International Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Hill's Pet Nutrition Inc., Ethos Veterinary Health LLC, Orion Corporation, Dechra Pharmaceuticals plc, Morris Animal Foundation, Vaxine Pty Ltd, Bioagile Therapeutics Pvt. Ltd., VetStem Inc., VetDC, Vivesto AB, OCRvet, Vetbiolix, Clinvet International, Ondax Scientific S.l., and Veterinary Research Management.
Strategic Acquisition Enhances Boehringer Ingelheim's Position in Pet Therapeutics
In September 2024, Boehringer Ingelheim Group, a pharmaceutical giant based in Germany, acquired Saiba Animal Health AG, a Switzerland-based biotechnology company specializing in novel therapeutics for chronic pet diseases. Although the purchase price was not disclosed, this acquisition strengthens Boehringer Ingelheim's animal health research and development capabilities, particularly in the fast-growing pet therapeutics segment, by integrating Saiba's cutting-edge technology platform into its R&D portfolio.
View the full veterinary clinical trials market report:
https://www.thebusinessresearchcompany.com/report/veterinary-clinical-trials-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Trends Focused on Novel Anti-Aging Therapies in Veterinary Trials
A notable trend in the veterinary clinical trials market is the pursuit of innovative anti-aging drugs aimed at extending the healthy lifespan of pets and enhancing their overall wellness. These novel medications are designed to slow or reverse aging processes and improve vitality in senior animals. For example, in February 2024, the US-based veterinary company Loyal initiated clinical trials for LOY-002, an anti-aging chewable pill targeting metabolic health in senior dogs. This drug is intended to counteract age-related health declines, ultimately supporting longer, healthier lives for dogs.
Large-Scale Clinical Research Targeting Senior Dogs Across the US
The ongoing LOY-002 trial, known as the STAY study, aims to enroll over 1,000 dogs aged 10 and older from more than 50 veterinary clinics throughout the United States. The study focuses on dogs of most sizes, excluding the smallest breeds, and seeks to assess improvements in metabolic function that could delay age-related diseases and enhance overall quality of life for aging pets.
Segment Breakdown and Market Forecasts for the Veterinary Clinical Trials Industry
This report categorizes the veterinary clinical trials market into several important segments:
1) By Animal Type: Livestock Animals, Companion Animals, and Other Animals
2) By Indications: Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology, Ophthalmology, Dermatology, and other categories
3) By Intervention Method: Medicines, Medical Devices, and Other Interventions
4) By End-User: Academics and Research Centers, Pharmaceutical and Biopharmaceutical Companies, and other end-users
Further subcategories include:
- Livestock Animals: Cattle, Sheep, Goats, Swine, Poultry
- Companion Animals: Dogs, Cats, Horses, Rabbits, Ferrets
- Other Animals: Wildlife, Exotic Pets, Laboratory Animals, Aquatic Animals
These classifications provide a comprehensive view of the diverse areas within veterinary clinical trials, highlighting the market's complexity and growth potential across different animal types, medical indications, intervention approaches, and user groups.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Companies Enhancing Their Presence in the Veterinary Clinical Trials Market here
News-ID: 4489800 • Views: …
More Releases from The Business Research Company
Market Trend Analysis: The Impact of Recent Advances on the Urology Catheters Ma …
The urology catheters market is on track for significant expansion over the coming years, driven by innovations and growing healthcare demands. As medical technologies evolve and patient care becomes more personalized, this market is poised to deliver enhanced solutions for urinary management. Below is an overview of the market's size, key players, emerging trends, and segment breakdown.
Projected Market Size and Growth Outlook for Urology Catheters
The urology catheters market…
Leading Companies Consolidating Their Presence in the Weight Loss Drugs Market
The weight loss drugs market is experiencing remarkable momentum, driven by scientific advancements and growing health concerns worldwide. As obesity rates surge, the demand for effective and innovative treatments is reshaping this industry. Let's explore the market's projected size, key players, emerging trends, and segment growth prospects to understand the current landscape and future trajectory.
Projected Size and Growth Outlook for the Weight Loss Drugs Market
The weight loss drugs…
Global Factors Influencing the Rapid Evolution of the Vulvodynia Treatment Marke …
The vulvodynia treatment market is poised for substantial growth as awareness and research into chronic vulvar pain conditions continue to increase. With advancements in therapies and a growing focus on personalized care, this market is attracting significant attention from healthcare providers and pharmaceutical companies alike. Let's explore the market's expected growth, key players, emerging trends, and segmentation in detail.
Projected Market Value and Expansion of the Vulvodynia Treatment Market
The…
Worldwide Factors Influencing the Rapid Evolution of the Venous Thromboembolism …
Understanding the future trajectory of the venous thromboembolism market reveals promising growth prospects driven by technological advancements and evolving treatment approaches. As healthcare continues to prioritize personalized and minimally invasive options, this market is set to experience steady expansion in the coming years. Let's explore the market's valuation, main players, emerging trends, and key segments shaping its development.
Expected Market Value and Growth of the Venous Thromboembolism Market by 2030 …
More Releases for Animal
Animal Health Market Sets the Table for Continued Growth : Zoetis Animal Healthc …
Advance Market Analytics published a new research publication on "Animal Health Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Health market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled…
Animal Antimicrobials and Antibiotics Market 2023 Growth and Development By Bion …
Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Animal Antimicrobials and Antibiotics includes Premixes, Oral Powders, Oral Solutions and Injections on the base of classification, which represent 12.4%, 14.4%, 10.4% and 56.6% of global Animal Antimicrobials and Antibiotics market.
Get Sample Copy: https://www.worldwidemarketreports.com/sample/273708
Farm Animals and Companion Animals are the…
Animal Healthcare Market Analysis Focusing on Top Key Players - Merck, Bayer Ani …
Worldwide Market Reports recently released on the Animal Healthcare market for the forecast period, 2017 – 2022 is involved in screening the business environment and the companies operating in the Animal Healthcare industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on the basis of…
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market
Developing Regions to Overpower Developed Ones With Regard to Demand
The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their…
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,…
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report…
